GlassScriptPhysician profile
David A Miller
NPI 1851340103
$4,886.57
in general payments reported to CMS, 2019-2025
30 companies · $702 in 2025
The $702 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,213 · 2020: $305 · 2021: $888 · 2022: $323 · 2023: $654 · 2024: $801 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.91 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,412.03 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $856.54 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $329.10 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.59 | 2019-2025 | Jardiance |
| Pfizer INC. | $253.44 | 2019-2025 | |
| Lilly USA, LLC | $239.28 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $172.43 | 2019-2021 | |
| Exact Sciences Corporation | $148.78 | 2023-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $125.35 | 2023 | Inspire |
| Abbvie INC. | $121.07 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $120.72 | 2019-2020 | |
| Bioventus LLC | $108.58 | 2024 | Exogen Ultrasound Bone Healing System |
| Bayer Healthcare Pharmaceuticals INC. | $103.25 | 2021-2024 | |
| Amgen INC. | $100.03 | 2023-2025 | Repatha, Otezla, Prolia |
| Astellas Pharma US INC | $79.99 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $54.99 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $43.61 | 2024-2025 | Dexcom G6 Transmitter |
| Alnylam Pharmaceuticals INC. | $37.97 | 2023-2024 | Onpattro |
| Otsuka America Pharmaceutical, INC. | $37.65 | 2023 | Rexulti, Nuedexta |
| Merck Sharp & Dohme LLC | $33.70 | 2021-2024 | Gardasil, Gardasil 9, Capvaxive |
| Intra-Sana Laboratories | $25.69 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Gilead Sciences, INC. | $24.32 | 2025 | |
| Sanofi Pasteur INC. | $22.91 | 2023 | |
| Jazz Pharmaceuticals INC. | $22.59 | 2022 | |
| Boston Scientific Corporation | $20.45 | 2025 | Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.32 | 2025 | Xifaxan |
| Smith+Nephew, INC. | $19.27 | 2025 | Collagenase Santyl |
| Novartis Pharmaceuticals Corporation | $18.08 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.79 | 2020 | |
| Allergan, INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.